−47.26 M USD
0.00 USD
25.15 M
About Sionna Therapeutics, Inc.
Sector
Industry
CEO
Michael Cloonan
Website
Headquarters
Waltham
Founded
2019
FIGI
BBG016X2DC85
Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a robust pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SION is 20.03 USD — it has decreased by −1.23% in the past 24 hours. Watch Sionna Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Sionna Therapeutics, Inc. stocks are traded under the ticker SION.
SION stock has fallen by −19.88% compared to the previous week, the month change is a −19.88% fall, over the last year Sionna Therapeutics, Inc. has showed a −19.88% decrease.
Yes, you can track Sionna Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
No, SION doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 15, 2025, the company has 28.00 employees. See our rating of the largest employees — is Sionna Therapeutics, Inc. on this list?
Like other stocks, SION shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sionna Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.